Please assess the completion status of the following clinical trial:

Trial Title: Daily Zinc Supplement Effect on Prevention of Diarrhea and Acute Respiratory Infections in Children Less Than Five Years

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Apparently healthy child with good general health~Exclusion Criteria:~* Children with severe malnutrition requiring hospital admission,~* Cases of chronic and metabolic diseases as diabetic children~* Children suffering from any type of cancer or any other debilitating disease.

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 5 Years
- Healthy Volunteers: t

Study Arms:
- zinc group (Type: ACTIVE_COMPARATOR): The children were randomized to receive daily zinc sulphate. The elemental zinc dose was 3 mg/ day to children whose weight is less than 10 kg and 7 mg/ day to children whose weight is 10 kg or more.
- placebo group (Type: PLACEBO_COMPARATOR): The placebo was non-nutritious and vitamin-free, designed to be identical to the zinc syrup in colour, odour, consistency and taste. Zinc and placebo syrups were packaged in similar bottles.

Based on this trial design, predict the completion outcome and termination type (if applicable).